PROVAX
PHARMACEUTICAL COMPOSITIONS FOR USE IN IMMUNOTHERAPY COMPRISING ADJUVANT-ANTIGEN FORMULATIONS, NAMELY, PROPHYLACTIC AND THERAPEUTIC VACCINES FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFECTIOUS DISEASES IN HUMANS
Cancelled · March 2, 1998 · 75442605 ·